Loading...
Prestige Consumer Healthcare Inc.
PBH•NYSE
Healthcare
Medical - Distribution
$76.88
$0.60(0.79%)
Prestige Consumer Healthcare Inc. (PBH) Financial Performance & Income Statement Overview
Review Prestige Consumer Healthcare Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-0.21%
↓ 0.21%
Operating Income Growth
-0.88%
↓ 0.88%
Net Income Growth
354.34%
↑ 354.34%
Operating Cash Flow Growth
8.36%
↑ 8.36%
Operating Margin
29.60%
↑ 29.60%
Gross Margin
55.76%
↑ 55.76%
Net Profit Margin
18.86%
↑ 18.86%
ROE
12.20%
↑ 12.20%
ROIC
10.22%
↑ 10.22%
Prestige Consumer Healthcare Inc. (PBH) Income Statement & Financial Overview
Review Prestige Consumer Healthcare Inc.'s (PBH) income statement with detailed quarterly and annual figures.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $290.32M | $283.55M | $267.14M | $276.99M |
| Cost of Revenue | $129.27M | $126.17M | $126.82M | $130.86M |
| Gross Profit | $161.05M | $157.38M | $140.32M | $146.13M |
| Gross Profit Ratio | $0.55 | $0.56 | $0.53 | $0.53 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $64.13M | $67.48M | $68.28M | $63.98M |
| Operating Expenses | $69.09M | $73.04M | $68.28M | $63.98M |
| Total Costs & Expenses | $198.35M | $199.21M | $195.10M | $194.84M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $11.46M | $12.28M | $13.14M | $15.26M |
| Depreciation & Amortization | $6.87M | $5.57M | $8.12M | $7.84M |
| EBITDA | $98.48M | $89.51M | $80.17M | $90.00M |
| EBITDA Ratio | $0.34 | $0.32 | $0.30 | $0.32 |
| Operating Income | $91.96M | $84.34M | $72.05M | $82.15M |
| Operating Income Ratio | $0.32 | $0.30 | $0.27 | $0.30 |
| Other Income/Expenses (Net) | -$11.81M | -$12.68M | -$13.63M | -$14.83M |
| Income Before Tax | $80.15M | $71.66M | $58.41M | $67.32M |
| Income Before Tax Ratio | $0.28 | $0.25 | $0.22 | $0.24 |
| Income Tax Expense | $19.12M | $17.29M | $9.35M | $17.86M |
| Net Income | $61.03M | $54.38M | $49.07M | $49.46M |
| Net Income Ratio | $0.21 | $0.19 | $0.18 | $0.18 |
| EPS | $1.23 | $1.10 | $0.98 | $0.99 |
| Diluted EPS | $1.22 | $1.09 | $0.98 | $0.98 |
| Weighted Avg Shares Outstanding | $49.60M | $49.65M | $49.89M | $49.83M |
| Weighted Avg Shares Outstanding (Diluted) | $49.99M | $50.00M | $50.27M | $50.31M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan